论文部分内容阅读
目的 :就剖宫产时同行子宫肌瘤剔除术的可行性与安全性作以探讨。方法 :取2015年5月~2016年11月我院接诊的妊娠并发子宫肌瘤的28例患者为研究对象,按剖宫产时是否同行子宫肌瘤剔除术将纳入患者分为同行剖宫产与子宫肌瘤剔除术的观察组与单行剖宫产的对照组,依据两组术中出血量、手术时间、肛门排气时间、住院时间、恶露排尽时间与产褥期并发症发生情况比较结果,判定剖宫产术与子宫肌瘤剔除术同行的可行性与安全性。结果 :除手术时间与术中出血量外,两组前述指标中其他比较指标无明显差异不具备统计学意义(P<0.05)。结论 :术者在熟练掌握子宫肌瘤剔除术操作步骤与技巧的前提情况下剖宫产与子宫肌瘤剔除术同行是可行且安全的,同行开展两种手术的优势是使患者免受二次手术痛苦,最大限度地降低子宫切除风险。
Objective: To investigate the feasibility and safety of myomectomy during cesarean section. Methods: From May 2015 to November 2016 in our hospital admissions of pregnancy complicated by uterine fibroids in 28 patients as the study, according to whether the same line of cesarean myomectomy will be included in the patients into the same hospital for cesarean section According to the results of comparisons between the two groups of intraoperative blood loss, operation time, anal exhaust time, length of stay, time to discharge lochia and complications during puerperium , To determine the feasibility and safety of cesarean section and myomectomy counterparts. Results: Except for the operation time and intraoperative blood loss, there was no significant difference between the other two indexes (P <0.05). CONCLUSIONS: It is feasible and safe for the surgeon to master the procedures and techniques of myomectomy to cesarean section and myomectomy. The advantage of the two kinds of operations performed by colleagues is to make the patient free from secondary Surgery to minimize the risk of hysterectomy.